2017
DOI: 10.1016/j.bmcl.2016.11.049
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of dual positive allosteric modulators (PAMs) of the metabotropic glutamate 2 receptor and CysLT1 antagonists for treating migraine headache

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 29 publications
0
2
0
Order By: Relevance
“…Moreover, it also possessed significant antagonist potency against cysteinyl leukotriene receptor 1 (its antagonist is considered as an approach for preventing and treating recurrent primary headaches). The outcomes of further in vivo assays showed that compound 113 exhibited a full therapeutic effect in the migraine rat model . The design of this multitarget compound with 113 as an example would provide a feasible approach to develop more effective agents for treating migraine headaches.…”
Section: Application Of De Scaffold In Medicinal Chemistrymentioning
confidence: 99%
See 1 more Smart Citation
“…Moreover, it also possessed significant antagonist potency against cysteinyl leukotriene receptor 1 (its antagonist is considered as an approach for preventing and treating recurrent primary headaches). The outcomes of further in vivo assays showed that compound 113 exhibited a full therapeutic effect in the migraine rat model . The design of this multitarget compound with 113 as an example would provide a feasible approach to develop more effective agents for treating migraine headaches.…”
Section: Application Of De Scaffold In Medicinal Chemistrymentioning
confidence: 99%
“…The outcomes of further in vivo assays showed that compound 113 exhibited a full therapeutic effect in the migraine rat model. 148 The design of this multitarget compound with 113 as an example would provide a feasible approach to develop more effective agents for treating migraine headaches.…”
Section: ■ Introductionmentioning
confidence: 99%